MediPoint: Kyphoplasty Devices - Global Analysis and Market Forecasts

MediPoint: Kyphoplasty Devices - Global Analysis and Market Forecasts

  • April 2017 •
  • Report ID: 4978316 •
  • Format: PDF
MediPoint: Kyphoplasty Devices - Global Analysis and Market Forecasts

Summary

Vertebroplasty and kyphoplasty are minimally invasive, fluoroscopy-guided surgical techniques that utilize acrylic cement injected into the damaged vertebral body to stabilize the fracture. Kyphoplasty is an advanced version of the conventional vertebroplasty procedure; prior to cement injection, a balloon is inflated in the fractured vertebral body to create a cavity and restore the vertebrae’s height. This procedure restores the pre-fracture vertebral body shape and height in addition to relieving pain and helping the patient regain function.

The global kyphoplasty market was estimated at $881.4M in 2016 across the 39 markets covered in this report. By the end of the forecast period in 2023, it is estimated that market will grow to approximately $1.6B at a Compound Annual Growth Rate (CAGR) of 9.3%.

Key drivers of the kyphoplasty market in the forecast period are -
- The rising prevalence of osteoporosis and osteopenia due to the increasing aging population.
- The increasing preference for minimally invasive and outpatient procedures.

The North American kyphoplasty market is projected to grow at a CAGR of 11.1% during the forecast period, followed by Middle East and Africa, APAC and South America at a CAGR of 10.4%, 8.6% and 7.5% respectively. European kyphoplasty market is projected to grow at a CAGR of 4.9% during the forecast period. The US represented the largest portion of the market in 2016, holding more than 90.0% of the regional revenue, and is expected to maintain this dominance through the forecast period.

Market for VCF repair products, including kyphoplasty balloons and kits, is a highly consolidated market. Together, three orthopedic conglomerates-DePuy Synthes, Medtronic, and Stryker-dominated the global market in 2016. These companies hold well-established orthopedic portfolios and enjoy wide-ranging distribution networks, which allow them to effectively cross-sell their VCF products. Several minor players also operate in regional markets, and domestic manufacturers of cheap copycat products are a threat in developing countries.

The report "MediPoint: Kyphoplasty Devices - Global Analysis and Market Forecasts" focuses on the market outlook for kyphoplasty products globally. The analysis discusses the major drivers and barriers of adoption, and provides an in-depth understanding of the future outlook for this market by segment and by region.

In particular, this report provides the following -
- Outlook of sales volume, pricing trends, revenue trends with 2016 as base year and forecasts until 2023, for kyphoplasty.
- Company share analysis in 2016, for VCF Repair (kyphoplasty and vertebroplasty)
- Market insights and competitive assessment of the key players within the kyphoplasty market.

Companies mentioned in this report: DePuy Synthes, Globus Medical, Medtronic, Stryker.

*Note: This is an on-demand report and will be delivered within 3 working days (excluding weekends) of the purchase.

Scope

- Outlook of sales volume, pricing trends, revenue trends with 2016 as base year and forecasts until 2023, for kyphoplasty.
- Company share analysis in 2016, for VCF Repair (kyphoplasty and vertebroplasty)
- Market insights and competitive assessment of the key players within the kyphoplasty market.

Reasons to Buy

- Identify the unmet needs and understand physicians’ perceptions of the current kyphoplasty devices.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global kyphoplasty market in the future0
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.